[HTML][HTML] Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod
G Siddiqui, H Maloni, VE Nava - The Egyptian Journal of Neurology …, 2021 - Springer
To the editor, We appreciated Mansoor and colleagues review entitled “COVID-19 pandemic
and the risk of infection in multiple sclerosis patients on disease-modifying therapies:“what …
and the risk of infection in multiple sclerosis patients on disease-modifying therapies:“what …
[HTML][HTML] Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination
IA Al Thubaiti, MM AlKhawajah, N Al Fugham… - Clinical and …, 2023 - mdpi.com
This article deals with recommendations on the management of symptoms of MS and on the
provision of vaccinations in patients receiving disease-modifying therapies (DMTs) …
provision of vaccinations in patients receiving disease-modifying therapies (DMTs) …
[HTML][HTML] Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional …
MR Fattahi, A Iranmehr, R Saeedi… - Current Journal of …, 2022 - ncbi.nlm.nih.gov
Background: Despite special global considerations which have been made to prioritize
vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This …
vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This …